Marginum is a university-based medical technology startup developing fluorescence-based tissue
detection systems. The Company’s data-driven solutions enable safe and efficient monitoring of tumor
tissues during cancer surgery without compromising pre-existent surgical workflows. The products are
derived from state-of-the-art research to improve surgical performance and cost-effectiveness.
Marginum’s multidisciplinary team works in close cooperation with academic, clinical and industrial
experts to ensure its technological solutions’ seamless clinical compatibility.